QT interval prolongation and rhabdomyolysis associated with diphenhydramine toxicity: a case report
- PMID: 32850053
- PMCID: PMC7425623
- DOI: 10.1080/20009666.2020.1749511
QT interval prolongation and rhabdomyolysis associated with diphenhydramine toxicity: a case report
Abstract
Diphenhydramine is a widely available, over-the-counter medication used for allergies and as a sleeping aid. When used in prescription doses, it is generally safe. Overdose of the medication has been associated with dangerous and life-threatening outcomes. Our case describes diphenhydramine toxicity manifesting with two rare but potentially life-threatening complications, rhabdomyolysis, and QT prolongation. Laboratory testing for diphenhydramine levels are not widely available. We recommend a high degree of suspicion for these complications when evaluating patients with diphenhydramine overdose, to adequately manage and prevent untoward outcomes.
Keywords: Diphenhydramine toxicity; QTC prolongation; anticholinergic toxidrome; rhabdomyolysis.
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.
Conflict of interest statement
No potential conflict of interest was reported by the authors.
References
-
- Simonsen LP. What are pharmacists dispensing most often. Pharm Times. 1991. April;3:57–71.
-
- Rickels K, Morris RJ, Newman H, Rosenfeld H, Schiller H, Weinstock R.. Diphenhydramine in insomniac family practice patients: a double‐blind study. J Clin Pharmacol. 1983. May 6;23(5‐6):234–242. - PubMed
-
- Emadian SM, Caravati EM, Herr RD.. Rhabdomyolysis: a rare adverse effect of diphenhydramine overdose. Am J Emergency Med. 1996. October 1;14(6):574–576. - PubMed
Publication types
LinkOut - more resources
Full Text Sources